Showing results (2211-2220 of 2,456) with videos related to

Sort By:
Pageof 246
BMC Urology|June 11, 2021
Exploring microRNA target genes and identifying hub genes in bladder cancer based on bioinformatic analysisHongjian Wu, Wubing Jiang, Guanghua Ji, et al.
BMC Urology|April 30, 2022
Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19Alfred Chung Pui So, Christina Karampera, Muhammad Khan, et al.
BMC Urology|July 12, 2022
Renal pelvis mucosal artery hemorrhage after percutaneous nephrolithotomy: a rare case report and literature reviewLv Wen Zhang, Xiang Fei, Yan Song
BMC Urology|July 12, 2022
A review of reproducible and transparent research practices in urology publications from 2014 to2018Shelby Rauh, Bradley S Johnson, Aaron Bowers, et al.
BMC Urology|July 19, 2022
Pericardial malignant infiltration as the cause of sudden death of a patient with metastatic urothelial carcinoma treated with atezolizumabPatrik Palacka, Pavol Janega, Hana Polakova, et al.
BMC Urology|July 28, 2022
Evaluation of cystoprostatectomy on patients with prostate cancer extending to bladder: a retrospective study from single centerXiaoliang Sun, Min Liu, Yong Zhao, et al.
BMC Urology|July 27, 2022
Is it necessary to perform a retrosigmoid transposition of the left ureter in Bricker Ileal Conduit surgery?Jinyou Wang, Zhouting Tuo, Mingzhu Gao, et al.
BMC Urology|September 23, 2015
Patient's adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?Luca Cindolo, Luisella Pirozzi, Petros Sountoulides, et al.
BMC Urology|October 27, 2015
Simplified scoring of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: a comparative analysis of test performance at different cut-off pointsPeter Joseph Jongen, Bertil F Blok, John P Heesakkers, et al.
BMC Urology|October 27, 2015
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective seriesDaniel S Engeler, Daniel Meyer, Dominik Abt, et al.
Pageof 246